{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:18:16Z","timestamp":1788401896449,"version":"build-2803163510"},"reference-count":178,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["APP1074016"],"award-info":[{"award-number":["APP1074016"]}]},{"name":"Australian National Health and Medical Research Council","award":["APP1098848"],"award-info":[{"award-number":["APP1098848"]}]},{"name":"Australian National Health and Medical Research Council","award":["APP1102365"],"award-info":[{"award-number":["APP1102365"]}]},{"name":"Australian National Health and Medical Research Council","award":["APP1093378"],"award-info":[{"award-number":["APP1093378"]}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.drudis.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T17:32:44Z","timestamp":1452965564000},"page":"725-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Defining the targets of antiparasitic compounds"],"prefix":"10.1016","volume":"21","author":[{"given":"Tina S.","family":"Skinner-Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subathdrage D.M.","family":"Sumanadasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-7573","authenticated-orcid":false,"given":"Rohan A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise L.","family":"Doolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine T.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2016.01.002_bib0900","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2016.01.002_bib0905","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2217\/fmb.11.88","article-title":"Drug resistance in human African trypanosomiasis","volume":"6","author":"Barrett","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.drudis.2016.01.002_bib0910","series-title":"World Malaria Report","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.drudis.2016.01.002_bib0915","series-title":"Control of the Leishmaniases","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.drudis.2016.01.002_bib0920","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1080\/21645515.2015.1059981","article-title":"Still hope for schistosomiasis vaccine","volume":"11","author":"Ricciardi","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.drudis.2016.01.002_bib0925","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.01.002_bib0930","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.drudis.2015.06.009","article-title":"Supporting malaria elimination with 21st century antimalarial agent drug discovery","volume":"20","author":"Diagana","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2016.01.002_bib0935","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.drudis.2016.01.002_bib0940","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"Pink","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2016.01.002_bib0945","first-page":"1","article-title":"Schistosomiasis therapeutics: whats in the pipeline?","author":"Trainor-Moss","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.drudis.2016.01.002_bib0950","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1021\/jm400443k","article-title":"Phenotypic screening as a strategic component of drug discovery programs targeting novel antiparasitic and antimycobacterial agents: an Editorial","volume":"56","author":"Butera","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib0955","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijpddr.2014.05.001","article-title":"Target-based vs. phenotypic screenings in Leishmania drug discovery: a marriage of convenience or a dialogue of the deaf?","volume":"4","author":"Reguera","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.drudis.2016.01.002_bib0960","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/QCO.0b013e328349156f","article-title":"Schistosomiasis: from drug deployment to drug development","volume":"24","author":"Caffrey","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib0965","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molbiopara.2011.01.007","article-title":"Quantitative retrotransposon anchored PCR confirms transduction efficiency of transgenes in adult Schistosoma mansoni","volume":"177","author":"Rinaldi","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib0970","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical genetics of Plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.01.002_bib0975","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.01.002_bib0980","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of inhibitors of Plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.drudis.2016.01.002_bib0985","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/AAC.04684-14","article-title":"Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation","volume":"59","author":"Miguel-Blanco","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib0990","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery \u2013 approaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2016.01.002_bib0995","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.01.002_bib1000","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.44.1.150-155.2000","article-title":"Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts","volume":"44","author":"Molina","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1005","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy \u2013 challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.drudis.2016.01.002_bib1010","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/AAC.02398-12","article-title":"Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay","volume":"57","author":"De Rycker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1015","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1128\/AAC.01777-09","article-title":"Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas\u2019 disease","volume":"54","author":"Engel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S0031182009991739","article-title":"In vitro and in vivo trematode models for chemotherapeutic studies","volume":"137","author":"Keiser","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.drudis.2016.01.002_bib1025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","article-title":"Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials","volume":"13","author":"Spillman","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2016.01.002_bib1030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baragana","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.01.002_bib1035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/AAC.43.2.278","article-title":"Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes","volume":"43","author":"Ephros","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1040","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/infdis\/151.6.1130","article-title":"Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo","volume":"151","author":"Xiao","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0020-7519(96)89380-5","article-title":"In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs","volume":"26","author":"Skinner","year":"1996","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1050","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.00642-07","article-title":"The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei","volume":"52","author":"Lanteri","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1055","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1073\/pnas.88.8.3382","article-title":"Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7","volume":"88","author":"Wellems","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.01.002_bib1060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nchembio.215","article-title":"Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum","volume":"5","author":"Yuan","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nmeth.3432","article-title":"Plasmodium falciparum genetic crosses in a humanized mouse model","volume":"12","author":"Vaughan","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.drudis.2016.01.002_bib1070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijpara.2012.03.004","article-title":"Analysis of malaria parasite phenotypes using experimental genetic crosses of Plasmodium falciparum","volume":"42","author":"Ranford-Cartwright","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chom.2008.06.001","article-title":"Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion","volume":"4","author":"Hayton","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2016.01.002_bib1080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/345253a0","article-title":"Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross","volume":"345","author":"Wellems","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.01.002_bib1085","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.3299700","article-title":"Genetic analysis of the human malaria parasite Plasmodium falciparum","volume":"236","author":"Walliker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.01.002_bib1090","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1365-2958.2004.04035.x","article-title":"Dissecting the loci of low-level quinine resistance in malaria parasites","volume":"52","author":"Ferdig","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/AAC.00916-10","article-title":"Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites","volume":"55","author":"Beez","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1100","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.01.002_bib1105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-4894(81)90101-6","article-title":"Plasmodium chabaudi: genetics of resistance to chloroquine","volume":"52","author":"Padua","year":"1981","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2307\/3281340","article-title":"Genetics of cross-resistance between antifolate drugs in Plasmodium yoelii","volume":"68","author":"Knowles","year":"1982","journal-title":"J. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4269\/ajtmh.1984.33.80","article-title":"Genetic analysis of hycanthone resistance in Schistosoma mansoni","volume":"33","author":"Cioli","year":"1984","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"Suppl. 4","key":"10.1016\/j.drudis.2016.01.002_bib1120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1590\/S0074-02761992000800032","article-title":"Genetic complementation analysis of two independently isolated hycanthone-resistant strains of Schistosoma mansoni","volume":"87","author":"Pica-Mattoccia","year":"1992","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.drudis.2016.01.002_bib1125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1006\/expr.1993.1104","article-title":"Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone\/oxamniquine-resistant strains are mutated in the same gene","volume":"77","author":"Pica-Mattoccia","year":"1993","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1130","first-page":"274","article-title":"Genetic analysis of praziquantel resistance in Schistosoma mansoni","volume":"34","author":"Liang","year":"2003","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.drudis.2016.01.002_bib1135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0031182000059114","article-title":"Analysis of a genetic cross between Trypanosoma brucei rhodesiense and T. b. brucei","volume":"99","author":"Gibson","year":"1989","journal-title":"Parasitology"},{"key":"10.1016\/j.drudis.2016.01.002_bib1140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0166-6851(89)90056-X","article-title":"Gene exchange in African trypanosomes: frequency and allelic segregation","volume":"34","author":"Sternberg","year":"1989","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1145","doi-asserted-by":"crossref","first-page":"e19851","DOI":"10.1371\/journal.pone.0019851","article-title":"Visualisation of Leishmania donovani fluorescent hybrids during early stage development in the sand fly vector","volume":"6","author":"Sadlova","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2016.01.002_bib1150","doi-asserted-by":"crossref","first-page":"34827","DOI":"10.1074\/jbc.M114.615831","article-title":"The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages","volume":"289","author":"Ke","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2164-10-128","article-title":"Developmental gene expression profiles of the human pathogen Schistosoma japonicum","volume":"10","author":"Gobert","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.drudis.2016.01.002_bib1160","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1128\/AAC.02721-13","article-title":"Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules","volume":"58","author":"Trenholme","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/expr.1993.1010","article-title":"Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria","volume":"76","author":"ter Kuile","year":"1993","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1170","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1462-5822.2008.01270.x","article-title":"Type II fatty acid synthesis is essential only for malaria parasite late liver stage development","volume":"11","author":"Vaughan","year":"2009","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nchembio.87","article-title":"Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility","volume":"4","author":"Kato","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1180","first-page":"197","article-title":"Azithromycin in the treatment of Plasmodium falciparum gametocytes. Preliminary observation","volume":"42","author":"Bregani","year":"2000","journal-title":"Panminerva Med."},{"key":"10.1016\/j.drudis.2016.01.002_bib1185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","article-title":"Sex-and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment","volume":"34","author":"Pica-Mattoccia","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1190","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1128\/AAC.00398-13","article-title":"Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis","volume":"57","author":"Wenzler","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1195","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/AAC.36.5.1091","article-title":"Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant","volume":"36","author":"Pfefferkorn","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1200","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/ncomms6521","article-title":"Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum","volume":"5","author":"Vaidya","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2016.01.002_bib1205","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"Wang","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.drudis.2016.01.002_bib1210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.01.002_bib1215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/AAC.03342-14","article-title":"A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0166-6851(84)90021-5","article-title":"Induction and selection of drug resistant mutants of Plasmodium falciparum","volume":"10","author":"Inselburg","year":"1984","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4269\/ajtmh.1985.34.417","article-title":"Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum","volume":"34","author":"Inselburg","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.drudis.2016.01.002_bib1230","doi-asserted-by":"crossref","first-page":"e1001138","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum","volume":"9","author":"Yeh","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1235","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/AAC.01500-13","article-title":"Anti-apicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the Malaria Box","volume":"58","author":"Bowman","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1240","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1074\/jbc.M105906200","article-title":"Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase","volume":"277","author":"Kicska","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1475-2875-13-343","article-title":"A novel approach for the discovery of chemically diverse anti-malarial compounds targeting the Plasmodium falciparum Coenzyme A synthesis pathway","volume":"13","author":"Fletcher","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.drudis.2016.01.002_bib1250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.27.4.525","article-title":"In vitro activities of and mechanisms of resistance to antifol antimalarial drugs","volume":"27","author":"Milhous","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1255","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1021\/jm0102809","article-title":"Activity of bisphosphonates against Trypanosoma brucei rhodesiense","volume":"45","author":"Martin","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1260","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/EC.00271-13","article-title":"Solanesyl diphosphate synthase, an enzyme of the ubiquinone synthetic pathway, is required throughout the life cycle of Trypanosoma brucei","volume":"13","author":"Lai","year":"2014","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.drudis.2016.01.002_bib1265","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1550-7408.1986.tb05599.x","article-title":"Polyamine depletion following exposure to dl-alpha-difluoromethylornithine both in vivo and in vitro initiates morphological alterations and mitochondrial activation in a monomorphic strain of Trypanosoma brucei brucei","volume":"33","author":"Giffin","year":"1986","journal-title":"J. Protozool."},{"key":"10.1016\/j.drudis.2016.01.002_bib1270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/expr.1995.1090","article-title":"Effects of bis(benzyl)polyamine analogs on Leishmania donovani promastigotes","volume":"81","author":"Mukhopadhyay","year":"1995","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1275","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00436-014-3868-y","article-title":"Ketanserin, an antidepressant, exerts its antileishmanial action via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) enzyme of Leishmania donovani","volume":"113","author":"Singh","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.drudis.2016.01.002_bib1280","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/AAC.00840-06","article-title":"Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro","volume":"51","author":"Skinner-Adams","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1285","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/AAC.00022-06","article-title":"Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin","volume":"50","author":"Parikh","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1290","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/AAC.00166-12","article-title":"Saquinavir inhibits the malaria parasite's chloroquine resistance transporter","volume":"56","author":"Martin","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1295","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2958.2007.05768.x","article-title":"Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function","volume":"65","author":"Bonilla","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1300","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1128\/AAC.00882-09","article-title":"Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors","volume":"53","author":"Moura","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1305","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.chembiol.2011.09.016","article-title":"Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors","volume":"18","author":"Dong","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1310","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.01305-09","article-title":"Probing the antimalarial mechanism of artemisinin and OZ277 (arterolane) with nonperoxidic isosteres and nitroxyl radicals","volume":"54","author":"Fugi","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1315","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/jm050691f","article-title":"Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole","volume":"49","author":"Benaim","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1320","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1128\/AAC.37.6.1353","article-title":"Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas\u2019 disease","volume":"37","author":"Maldonado","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1325","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00436-011-2786-5","article-title":"Ultrastructural analysis of miltefosine-induced surface membrane damage in adult Schistosoma mansoni BH strain worms","volume":"110","author":"Bertao","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.drudis.2016.01.002_bib1330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-511X-9-33","article-title":"Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids","volume":"9","author":"Jimenez-Lopez","year":"2010","journal-title":"Lipids Health Dis."},{"issue":"Suppl.","key":"10.1016\/j.drudis.2016.01.002_bib1335","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0031182005008346","article-title":"Ca2+ signalling, voltage-gated Ca2+ channels and praziquantel in flatworm neuromusculature","volume":"131","author":"Greenberg","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.drudis.2016.01.002_bib1340","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1128\/AAC.00394-06","article-title":"Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum","volume":"50","author":"Dahl","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1345","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1021\/jm400325j","article-title":"Using genetic methods to define the targets of compounds with antimalarial activity","volume":"56","author":"Flannery","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1350","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/jac\/dkp449","article-title":"In vitro selection of Plasmodium falciparum drug-resistant parasite lines","volume":"65","author":"Nzila","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1355","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/gb-2009-10-2-r21","article-title":"Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum","volume":"10","author":"Dharia","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1360","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/bioinformatics\/btq269","article-title":"Iterative correction of reference nucleotides (iCORN) using second generation sequencing technology","volume":"26","author":"Otto","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2016.01.002_bib1365","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2217\/fmb.11.45","article-title":"Target identification and validation of novel antimalarials","volume":"6","author":"McNamara","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1370","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drup.2009.01.001","article-title":"Resistance to antimalarial compounds: methods and applications","volume":"12","author":"Witkowski","year":"2009","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drudis.2016.01.002_bib1375","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/cb200105d","article-title":"A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome B inhibitor","volume":"6","author":"Nam","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1380","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.1011560108","article-title":"Validation of isoleucine utilization targets in Plasmodium falciparum","volume":"108","author":"Istvan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.01.002_bib1385","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.chom.2012.04.015","article-title":"Selective and specific inhibition of the Plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin","volume":"11","author":"Hoepfner","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2016.01.002_bib1390","doi-asserted-by":"crossref","first-page":"e2564","DOI":"10.1371\/journal.pntd.0002564","article-title":"Gene amplification and point mutations in pyrimidine metabolic genes in 5-fluorouracil resistant Leishmania infantum","volume":"7","author":"Ritt","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1395","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1371\/journal.pntd.0001512","article-title":"Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1400","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.ppat.1001204","article-title":"A molecular mechanism for eflornithine resistance in African trypanosomes","volume":"6","author":"Vincent","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2016.01.002_bib1405","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/00034983.1999.11813429","article-title":"The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides","volume":"93","author":"Peters","year":"1999","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1410","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1471-4922(01)01899-2","article-title":"Of mice and malaria mutants: unravelling the genetics of drug resistance using rodent malaria models","volume":"17","author":"Carlton","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpddr.2015.05.006","article-title":"Leishmania is not prone to develop resistance to tamoxifen","volume":"5","author":"Coelho","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.drudis.2016.01.002_bib1425","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1741-7007-9-21","article-title":"Toward forward genetic screens in malaria-causing parasites using the piggyBac transposon","volume":"9","author":"Crabb","year":"2011","journal-title":"BMC Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1430","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2307\/3275975","article-title":"Selection of strains of Plasmodium berghei resistant to quinine, chloroquine, and pyrimethamine","volume":"51","author":"Jacobs","year":"1965","journal-title":"J. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1435","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/261585a0","article-title":"Genetics of chloroquine resistance in malaria parasites","volume":"261","author":"Rosario","year":"1976","journal-title":"Nature"},{"issue":"Suppl. 4","key":"10.1016\/j.drudis.2016.01.002_bib1440","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/S0074-02761987000800025","article-title":"Drug resistance in schistosomiasis: a review","volume":"82","author":"Bruce","year":"1987","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.drudis.2016.01.002_bib1445","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4269\/ajtmh.1994.51.83","article-title":"Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific","volume":"51","author":"Fallon","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.drudis.2016.01.002_bib1450","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0001-706X(91)90002-2","article-title":"In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium","volume":"50","author":"Zhang","year":"1991","journal-title":"Acta Trop."},{"key":"10.1016\/j.drudis.2016.01.002_bib1455","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0031182097002084","article-title":"In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole","volume":"116","author":"Murta","year":"1998","journal-title":"Parasitology"},{"key":"10.1016\/j.drudis.2016.01.002_bib1460","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1093\/nar\/gkp239","article-title":"Molecular genetics and comparative genomics reveal RNAi is not functional in malaria parasites","volume":"37","author":"Baum","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drudis.2016.01.002_bib1465","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1128\/EC.05114-11","article-title":"RNA interference in protozoan parasites: achievements and challenges","volume":"10","author":"Kolev","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.drudis.2016.01.002_bib1470","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1096\/fj.15-271353","article-title":"A heteromeric potassium channel involved in the modulation of the plasma membrane potential is essential for the survival of African trypanosomes","volume":"29","author":"Steinmann","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2016.01.002_bib1475","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0031182009991168","article-title":"RNA interference in schistosomes: machinery and methodology","volume":"137","author":"Krautz-Peterson","year":"2010","journal-title":"Parasitology"},{"key":"10.1016\/j.drudis.2016.01.002_bib1480","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"Alsford","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2016.01.002_bib1485","doi-asserted-by":"crossref","first-page":"46596","DOI":"10.1074\/jbc.M309320200","article-title":"The adenosine analog tubercidin inhibits glycolysis in Trypanosoma brucei as revealed by an RNA interference library","volume":"278","author":"Drew","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1490","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2010.11.010","article-title":"Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6","volume":"176","author":"Baker","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1495","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1475-2875-10-242","article-title":"Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine","volume":"10","author":"Kritsiriwuthinan","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.drudis.2016.01.002_bib1500","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molbiopara.2012.09.006","article-title":"Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro","volume":"186","author":"Hines-Kay","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1505","doi-asserted-by":"crossref","first-page":"e1003254","DOI":"10.1371\/journal.ppat.1003254","article-title":"Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII","volume":"9","author":"You","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2016.01.002_bib1510","first-page":"29","article-title":"Advanced applications of RNA sequencing and challenges","volume":"9","author":"Han","year":"2015","journal-title":"Bioinform. Biol. Insights"},{"key":"10.1016\/j.drudis.2016.01.002_bib1515","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.csbj.2015.08.004","article-title":"Dynamics in transcriptomics: advancements in RNA-seq time course and downstream analysis","volume":"13","author":"Spies","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.drudis.2016.01.002_bib1520","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2008-9-7-r115","article-title":"Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy","volume":"9","author":"Ubeda","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1525","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1260403","article-title":"Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"Mok","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.01.002_bib1530","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.75.101304.124125","article-title":"Activity-based protein profiling: from enzyme chemistry to proteomic chemistry","volume":"77","author":"Cravatt","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1535","doi-asserted-by":"crossref","first-page":"E526","DOI":"10.1073\/pnas.1105601108","article-title":"Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases","volume":"108","author":"Harbut","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.01.002_bib1540","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nchembio.70","article-title":"Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum","volume":"4","author":"Arastu-Kapur","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1545","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1126\/science.1077426","article-title":"A role for the protease falcipain 1 in host cell invasion by the human malaria parasite","volume":"298","author":"Greenbaum","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.drudis.2016.01.002_bib1550","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1074-5521(00)00014-4","article-title":"Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools","volume":"7","author":"Greenbaum","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1555","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biochi.2007.08.013","article-title":"Differential use of protease families for invasion by schistosome cercariae","volume":"90","author":"Dvorak","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.drudis.2016.01.002_bib1560","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1002\/chem.201103322","article-title":"Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents","volume":"18","author":"Yang","year":"2012","journal-title":"Chemistry"},{"key":"10.1016\/j.drudis.2016.01.002_bib1565","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1016\/j.bmc.2009.08.039","article-title":"Rapid isolation of novel FK506 binding proteins from multiple organisms using gDNA and cDNA T7 phage display","volume":"17","author":"Piggott","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1570","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1074-5521(00)80018-6","article-title":"Display cloning: functional identification of natural product receptors using cDNA-phage display","volume":"6","author":"Sche","year":"1999","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1575","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpara.2010.08.002","article-title":"Plasmodium immunomics","volume":"41","author":"Doolan","year":"2011","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1580","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymeth.2011.06.006","article-title":"Leishmania cell-free protein expression system","volume":"55","author":"Kovtun","year":"2011","journal-title":"Methods"},{"key":"10.1016\/j.drudis.2016.01.002_bib1585","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chembiol.2009.01.006","article-title":"Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo","volume":"16","author":"Chen","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1590","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.chembiol.2004.08.015","article-title":"A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+\/calmodulin function","volume":"11","author":"Shim","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1595","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1475-2875-2-47","article-title":"Construction and use of Plasmodium falciparum phage display libraries to identify host parasite interactions","volume":"2","author":"Lauterbach","year":"2003","journal-title":"Malar. J."},{"key":"10.1016\/j.drudis.2016.01.002_bib1600","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/AAC.01222-08","article-title":"Praziquantel affects the regulatory myosin light chain of Schistosoma mansoni","volume":"53","author":"Gnanasekar","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1605","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.01.002_bib1610","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/cb100294v","article-title":"Identification of direct protein targets of small molecules","volume":"6","author":"Lomenick","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1615","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.drudis.2016.01.002_bib1620","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1475-2875-9-141","article-title":"Plasmodium falciparum proteome changes in response to doxycycline treatment","volume":"9","author":"Briolant","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.drudis.2016.01.002_bib1625","first-page":"19","article-title":"Comparison of proteome profiling of two sensitive and resistant field Iranian isolates of Leishmania major to glucantime(R) by 2-dimensional electrophoresis","volume":"10","author":"Zarean","year":"2015","journal-title":"Iran J. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1630","first-page":"237","article-title":"Partial characterization of Plasmodium falciparum trophozoite proteome under treatment with quinine, mefloquine and the natural antiplasmodial diosgenone","volume":"34","author":"Segura","year":"2014","journal-title":"Biomedica"},{"key":"10.1016\/j.drudis.2016.01.002_bib1635","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijpara.2005.02.008","article-title":"Protozoan genomes: gene identification and annotation","volume":"35","author":"Worthey","year":"2005","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1640","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S0031182013000814","article-title":"Determination of antiprotozoal drug mechanisms by metabolomics approaches","volume":"141","author":"Creek","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.drudis.2016.01.002_bib1645","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1371\/journal.pntd.0001618","article-title":"Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei","volume":"6","author":"Vincent","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1650","doi-asserted-by":"crossref","first-page":"8298","DOI":"10.1073\/pnas.1205651109","article-title":"Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria","volume":"109","author":"Biagini","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.01.002_bib1655","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1021\/bi200113y","article-title":"A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling","volume":"50","author":"Zhang","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2016.01.002_bib1660","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/AAC.03338-14","article-title":"Drug target identification using a trypanosome overexpression library","volume":"58","author":"Begolo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1665","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/AAC.00757-07","article-title":"Potent antimalarial activity of histone deacetylase inhibitor analogues","volume":"52","author":"Andrews","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.06.014","article-title":"Novel dialkylphosphorylhydrazones: synthesis, leishmanicidal evaluation and theoretical investigation of the proposed mechanism of action","volume":"101","author":"da Matta","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drudis.2016.01.002_bib1675","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.01.002_bib1680","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02851","article-title":"Global distribution maps of the leishmaniases","volume":"3","author":"Pigott","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.drudis.2016.01.002_bib1685","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1690","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-4362.1997.00022.x","article-title":"A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey","volume":"36","author":"Ozgoztasi","year":"1997","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1695","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1700","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1705","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.drudis.2016.01.002_bib1710","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0035-9203(03)90167-2","article-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline","volume":"97","author":"Rijal","year":"2003","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.drudis.2016.01.002_bib1715","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2016.01.002_bib1720","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2217\/fmb.11.44","article-title":"Development of novel drugs for human African trypanosomiasis","volume":"6","author":"Brun","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1725","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1371\/journal.pntd.0001007","article-title":"The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000\u20132009: the way forward","volume":"5","author":"Simarro","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1730","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2334-8-16","article-title":"Estimates of the duration of the early and late stage of gambiense sleeping sickness","volume":"8","author":"Checchi","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1735","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccc.2013.03.005","article-title":"Infections of the developing world","volume":"29","author":"Murthy","year":"2013","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.drudis.2016.01.002_bib1740","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4269\/ajtmh.1949.s1-29.173","article-title":"Mel B in the treatment of human trypanosomiasis","volume":"29","author":"Friedheim","year":"1949","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.drudis.2016.01.002_bib1745","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","article-title":"Eflornithine for the treatment of human African trypanosomiasis","volume":"90","author":"Burri","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.drudis.2016.01.002_bib1750","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1406.071266","article-title":"High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo","volume":"14","author":"Robays","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1755","series-title":"Chagas Disease: Control and Elimination. World Health Assembly Report","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.drudis.2016.01.002_bib1760","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacc.2013.05.046","article-title":"Chagas disease: an overview of clinical and epidemiological aspects","volume":"62","author":"Nunes","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.drudis.2016.01.002_bib1765","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1770","first-page":"1635","article-title":"Experience with nifurtimox in chronic Chagas\u2019 infection. Preliminary report","volume":"22","author":"Wegner","year":"1972","journal-title":"Arzneimittelforschung."},{"key":"10.1016\/j.drudis.2016.01.002_bib1775","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0037-86821997000200009","article-title":"Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas\u2019 disease, in a field area with interrupted transmission. I. Preliminary evaluation","volume":"30","author":"Coura","year":"1997","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.drudis.2016.01.002_bib1780","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/656917","article-title":"Tolerance and safety of nifurtimox in patients with chronic Chagas disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2016.01.002_bib1785","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1128\/AAC.00227-13","article-title":"Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods","volume":"57","author":"Munoz","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.01.002_bib1790","doi-asserted-by":"crossref","first-page":"e64450","DOI":"10.1371\/journal.pone.0064450","article-title":"Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease","volume":"8","author":"Pinto","year":"2013","journal-title":"PLoS One"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:25:06Z","timestamp":1761222306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644616000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":178,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1359644616000180"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2016.01.002","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the targets of antiparasitic compounds","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}